Diindolylmethane (DIM) for Cancer: Safety & Side Effects

This page covers safety information for Diindolylmethane (DIM). See our complete Diindolylmethane (DIM) therapy guide →

Authors

Olivia Pearman is an experienced researcher who is passionate about access to scientific information. She has over a decade of research experience with a PhD from the University of Colorado at Boulder, a Master’s from the Yale School of the Environment, and a Bachelor of Science from Clemson University. Throughout her career, she has honed her skills in translating research for all audiences and is thrilled to work with CancerChoices to help make scientific knowledge available for everybody.

Olivia Pearman, PhD Research Associate

Nancy Hepp, MS

past Lead Researcher
View profile

Ms. Hepp is a researcher and communicator who has been writing and editing educational content on varied health topics for more than 20 years. She serves as lead researcher and writer for CancerChoices and also served as the first program manager. Her graduate work in research and cognitive psychology, her master’s degree in instructional design, and her certificate in web design have all guided her in writing and presenting information for a wide variety of audiences and uses. Nancy’s service as faculty development coordinator in the Department of Family Medicine at Wright State University also provided experience in medical research, plus insights into medical education and medical care from the professional’s perspective.

Nancy Hepp, MS past Lead Researcher

Clinical reviewer

Laura Pole, MSN, RN, OCNS

Senior Clinical Consultant
View profile

Laura Pole is senior clinical consultant for CancerChoices. Laura is an oncology clinical nurse specialist who has been providing integrative oncology clinical care, navigation, consultation, and education services for over 40 years. She is the co-creator and co-coordinator of the Integrative Oncology Navigation Training at Smith Center for Healing and the Arts in Washington, DC. Laura also manages the “Media Watch Cancer News That You Can Use” listserv for Smith Center/Commonweal. In her role as a palliative care educator and consultant, Laura has served as statewide Respecting Choices Faculty for the Virginia POST (Physician Orders for Scope of Treatment) Collaborative as well as provided statewide professional education on palliative and end-of-life care for the Virginia Association for Hospices and Palliative Care.

For CancerChoices, Laura curates content and research, networks with clinical and organizational partners, brings awareness and education of integrative oncology at professional and patient conferences and programs, and translates research into information relevant to the patient experience as well as clinical practice.

Laura sees her work with CancerChoices as a perfect alignment of all her passions, knowledge and skills in integrative oncology care. She is honored to serve you.

Laura Pole, MSN, RN, OCNS Senior Clinical Consultant

Last update: November 19, 2026

Side effects and adverse reactions

DIM supplements are generally considered safe and side effects are usually mild. Common side effects include darkened pee, headache, nausea, diarrhea, and vomiting.1Thomson CA, Chow HHS et al. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Research and Treatment. 2017 Aug;165(1):97-107; Paltsev M, Kiselev V et al. Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN). EPMA J. 2014;5(1):18; Reed GA, Sunega JM, et al. Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3′-diindolylmethane in healthy subjects. Cancer Epidemiology, Biomarkers, and Prevention. 2008;17(10):2619-2624; Yerushalmi R, Bargil S et al. 3,3-Diindolylmethane (DIM): a nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trial. 2020;41(10):1395-1401.

There have been a few case reports of more severe adverse reactions, usually associated with high intake, including visual impairment,2Bussel II, Lally DR, Waheed NK. Bilateral central serous chorioretinopathy associated with estrogen modulator diindolylmethane. Ophthalmic Surgery, Lasers and Imaging Retina. 2014;45(6):589-591. rash,3Le TM, Sanders CJ, et al. Drug rash with eosinophilia and systemic symptoms caused by the dietary supplement diindolylmethane. Journal of Allergy and Clinical Immunology. 2016 Jan-Feb;4(1):175-6. ischemic stroke,4Pence ST, Mehta K, Crum-Bailey J. The Serious Side of Supplements: An Ischemic Stroke in a Healthy 38-year-old Female. Mil Med. 2023 Aug 29;188(9-10):e3273-e3275. and pulmonary embolism.5Bui PV, Moualla M, Upson DJ. A Possible Association of Diindolylmethane with Pulmonary Embolism and Deep Venous Thrombosis. Case Reports in Medicine. 2016;2016:7527098.

Contraindications

Pregnant and breastfeeding women, and women planning to get pregnant, should avoid DIM due to its potential effects on hormones. Women using birth control pills should consult with a physician before taking DIM.6Memorial Sloan Kettering Cancer Center. 2025. Diindolylmethane | Memorial Sloan Kettering Cancer Center. Accessed November 11, 2026.

Drug interactions 

There are known interactions with DIM supplements including with tamoxifen, hormonal medications, and liver medications.7Thomson CA, Chow HHS et al. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Research and Treatment. 2017 Aug;165(1):97-107; Diindolylmethane. Rx List. June 11, 2021. Viewed January 13, 2023. 

Interactions with medications and other interventions are complex. Always consult with a healthcare professional before adding any new therapy to your regimen. To learn more about interactions visit one of the trusted resources below: 

← Back to the full Diindolylmethane (DIM) therapy guide

References[+]